Gabelli upgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a hold rating to a buy rating in a research report sent to investors on Wednesday, Benzinga reports. Gabelli currently has $42.00 target price on the stock. The analysts noted that the move was a valuation call.
PAHC has been the subject of several other research reports. Zacks Investment Research raised shares of Phibro Animal Health from a sell rating to a hold rating in a report on Wednesday, January 23rd. BidaskClub raised shares of Phibro Animal Health from a sell rating to a hold rating in a report on Friday, March 22nd. Finally, ValuEngine cut shares of Phibro Animal Health from a hold rating to a sell rating in a report on Wednesday, February 13th. Three analysts have rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the company’s stock. The company currently has an average rating of Hold and an average target price of $43.20.
Shares of Phibro Animal Health stock traded up $0.30 during trading on Wednesday, hitting $31.16. 6,695 shares of the company’s stock were exchanged, compared to its average volume of 160,381. The company has a debt-to-equity ratio of 1.52, a current ratio of 3.25 and a quick ratio of 1.83. Phibro Animal Health has a 52-week low of $28.28 and a 52-week high of $54.62. The stock has a market cap of $1.46 billion, a PE ratio of 17.99, a price-to-earnings-growth ratio of 4.16 and a beta of 0.63.
Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Monday, May 6th. The company reported $0.39 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.43 by ($0.04). Phibro Animal Health had a return on equity of 36.37% and a net margin of 8.69%. The business had revenue of $205.70 million for the quarter, compared to analysts’ expectations of $214.94 million. During the same period last year, the business earned $0.46 EPS. The company’s revenue for the quarter was down 1.5% on a year-over-year basis. As a group, equities analysts expect that Phibro Animal Health will post 1.68 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 26th. Stockholders of record on Wednesday, June 5th will be paid a dividend of $0.12 per share. The ex-dividend date of this dividend is Tuesday, June 4th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.54%. Phibro Animal Health’s dividend payout ratio is currently 27.59%.
Several hedge funds have recently added to or reduced their stakes in the company. Advisory Services Network LLC increased its stake in shares of Phibro Animal Health by 20.4% during the fourth quarter. Advisory Services Network LLC now owns 2,195 shares of the company’s stock worth $71,000 after purchasing an additional 372 shares in the last quarter. Victory Capital Management Inc. boosted its position in Phibro Animal Health by 4.1% during the fourth quarter. Victory Capital Management Inc. now owns 10,756 shares of the company’s stock worth $346,000 after acquiring an additional 419 shares during the last quarter. Algert Global LLC boosted its position in Phibro Animal Health by 1.6% during the fourth quarter. Algert Global LLC now owns 28,849 shares of the company’s stock worth $928,000 after acquiring an additional 464 shares during the last quarter. Quantamental Technologies LLC boosted its position in Phibro Animal Health by 26.0% during the first quarter. Quantamental Technologies LLC now owns 2,358 shares of the company’s stock worth $78,000 after acquiring an additional 487 shares during the last quarter. Finally, Texas Permanent School Fund boosted its position in Phibro Animal Health by 4.1% during the first quarter. Texas Permanent School Fund now owns 13,773 shares of the company’s stock worth $455,000 after acquiring an additional 548 shares during the last quarter. 50.78% of the stock is owned by institutional investors and hedge funds.
About Phibro Animal Health
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.
Recommended Story: 12b-1 Fees